PMO Interview with the Innovator Series: Volume 5
Michael Pellini, MD
Video Categories: PMO Interview with the Innovator Series
Michael Pellini, President and Chief Executive Officer of Foundation Medicine, offers a definition of personalized medicine in this new video series from Personalized Medicine in Oncology.
Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later